Search hospitals > Colorado > Denver
Rose Medical Center
Claim this profileDenver, Colorado 80220
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Lymphoma
293 reported clinical trials
3 medical researchers
Summary
Rose Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Breast cancer, Lymphoma and other specialties. Rose Medical Center is involved with conducting 293 clinical trials across 406 conditions. There are 3 research doctors associated with this hospital, such as Nicholas DiBella, Andrew S. Kennedy, and Keren Sturtz.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Andrew S. KennedyHenrico Doctor's Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Esophageal Cancer
7 reported clinical trials
28 drugs studied
Keren SturtzSCL Health Lutheran Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
4 reported clinical trials
14 drugs studied
Clinical Trials running at Rose Medical Center
Breast Cancer
Lung Cancer
Cutaneous Melanoma
Melanoma
Skin Cancer
Non-Small Cell Lung Cancer
Breast cancer
Parotid Gland Cancer
Esophageal cancer
Multiple Myeloma
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Questionnaire Choice
for Cancer Data Quality
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Recruiting1 award N/A11 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rose Medical Center?
Rose Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Breast cancer, Lymphoma and other specialties. Rose Medical Center is involved with conducting 293 clinical trials across 406 conditions. There are 3 research doctors associated with this hospital, such as Nicholas DiBella, Andrew S. Kennedy, and Keren Sturtz.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.